Clinical Trial Update: Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole [Phase 4]

View source ↗

Summary

Phase 4 trial comparing small bowel lesions linked to celecoxib versus ibuprofen with omeprazole completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Diseases

Drugs mentioned

• Celecoxib (Celecoxib)
• Ibuprofen plus omeprazole

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bowel Diseases, Inflammatory | Phase 4 | Status: COMPLETED